| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| OSTEOPORE Aktie jetzt für 0€ handeln | |||||
| Fr | OSTEOPORE LIMITED: Appendix 4E Preliminary Final Report | 1 | ASX | ||
| Mo | OSTEOPORE LIMITED: Change in substantial holding | - | ASX | ||
| So | OSTEOPORE LIMITED: OSX and TTSH secure additional funding for novel implant | 1 | ASX | ||
| 16.02. | OSTEOPORE LIMITED: Notification regarding unquoted securities - OSX | - | ASX | ||
| 16.02. | OSTEOPORE LIMITED: Cleansing Notice | 1 | ASX | ||
| 16.02. | OSTEOPORE LIMITED: Drawdown of Tranche 2 of the Redeemable Convertible Notes | 1 | ASX | ||
| 16.02. | OSTEOPORE LIMITED: Change in substantial holding | 1 | ASX | ||
| 12.02. | OSTEOPORE LIMITED: OSX secures Latin America deal for craniofacial distribution | 1 | ASX | ||
| 12.02. | OSTEOPORE LIMITED: Change in substantial holding | - | ASX | ||
| 12.02. | OSTEOPORE LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 11.02. | OSTEOPORE LIMITED: Application for quotation of securities - OSX | 2 | ASX | ||
| 09.02. | OSTEOPORE LIMITED: OSX establishes new business in 3D printing services | - | ASX | ||
| 09.02. | OSTEOPORE LIMITED: Change in substantial holding | - | ASX | ||
| 06.02. | OSTEOPORE LIMITED: Notification regarding unquoted securities - OSX | - | ASX | ||
| 06.02. | OSTEOPORE LIMITED: Cleansing Notice | - | ASX | ||
| 06.02. | OSTEOPORE LIMITED: Further Drawdown of T1 of the Redeemable Convertible Notes | 1 | ASX | ||
| 04.02. | OSTEOPORE LIMITED: Change in substantial holding | - | ASX | ||
| 03.02. | OSTEOPORE LIMITED: Application for quotation of securities - OSX | - | ASX | ||
| 30.01. | OSTEOPORE LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 29.01. | OSTEOPORE LIMITED: Activities Report December 2025 and Appendix 4C | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 50,90 | -0,82 % | DAX-Check: BMW, Fresenius, Hochtief, MTU, Vonovia, Zalando | Donald Trump wirbelt die Märkte mal wieder durcheinander. Der US-Präsident kündigte neue globale Zölle an. Zuvor hatte der Supreme Court die bisherigen Zollmaßnahmen für unrechtmäßig erklärt. Die Unsicherheit... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,140 | -0,59 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,220 | -5,83 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,470 | +0,64 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| GERRESHEIMER | 16,950 | +7,96 % | Gerresheimer: Nach Kursdebakel - Jetzt das große Comeback? | ||
| BRIGHTSPRING HEALTH SERVICES | 41,380 | +3,14 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,120 | -0,59 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,670 | -4,10 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| OTTOBOCK | 57,00 | +1,97 % | Aktien KW 8. News. Knorr Bremse. Jost. Norma Group. Ottobock. HHLA. STEYR Motors. Deutsche Rohstoff. Hapag Lloyd. technotrans | Aktien: Beim DAX konnte man letztendlich die 25.000er Marke behaupten. Wäre eigentlich eine schöne Ausgangsbasis für weitere Kursavancen. Aber die Unsicherheit über die Entwicklung im Nahen Osten mit... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,420 | +1,65 % | EQS-AFR: Eckert & Ziegler SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Eckert & Ziegler SE
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Eckert & Ziegler SE: Vorabbekanntmachung... ► Artikel lesen | |
| PROGYNY | 17,685 | -20,55 % | Progyny, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| GENEDX | 79,77 | -1,87 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| ESSILORLUXOTTICA | 225,00 | 0,00 % | Ray-Ban Meta: Preisfrage sorgt offenbar für Spannungen | ||
| ONEMEDNET | 1,030 | +53,27 % | OneMedNet-Aktie steigt nach Plattform-Launch um 90 % | ||
| PRIVIA HEALTH GROUP | 23,730 | -4,81 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen |